Concepedia

Lori D. Bash

LD

29

Publications

2.7K

Citations

22

H-Index

2008

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Johns Hopkins University

Stiftung Institut für Herzinfarktforschung

Brigham and Women's Hospital

MSD (UK) Limited (United Kingdom)

Lori D. Bash is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, cardiovascular disease, and public health.

ORCID

Top concepts

Publications per year

2008–2023

29

Publications

29

Risk Implications of the New CKD Epidemiology Collaboration (CKD-EPI) Equation Compared With the MDRD Study Equation for Estimated GFR: The Atherosclerosis Risk in Communities (ARIC) Study

Kunihiro Matsushita, Elizabeth Selvin, Lori D. Bash et al. · American Journal of Kidney Diseases · 2010 · 310 citations

, , +12

Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER)

Sachin Kheterpal, Michelle T. Vaughn, Timur Dubovoy et al. · Anesthesiology · 2020 · 287 citations · Full text

Change in Estimated GFR Associates with Coronary Heart Disease and Mortality

Kunihiro Matsushita, Elizabeth Selvin, Lori D. Bash et al. · Journal of the American Society of Nephrology · 2009 · 273 citations · Full text

Poor Glycemic Control in Diabetes and the Risk of Incident Chronic Kidney Disease Even in the Absence of Albuminuria and Retinopathy

Lori D. Bash, Elizabeth Selvin, Michael Steffes et al. · Archives of Internal Medicine · 2008 · 184 citations · Full text

Heart Rate Variability Predicts ESRD and CKD-Related Hospitalization

Daniel J. Brotman, Lori D. Bash, Rehan Qayyum et al. · Journal of the American Society of Nephrology · 2010 · 159 citations · Full text

, , +16

Rows per page

1–5 of 29